Citius Pharmaceuticals, Inc. (“Citius” or the “Company”) (Nasdaq: CTXR), a specialty pharmaceutical company focused on developing and commercializing critical care drug products, announced today that the company will deliver a presentation at the MoneyShow Las Vegas Virtual Expo that is being held August 18 – 20, 2020. E
| CRANFORD, N.J., Aug. 13, 2020 /PRNewswire/ -- Citius Pharmaceuticals, Inc. (“Citius” or the “Company”) (Nasdaq: CTXR), a specialty pharmaceutical company focused on developing and commercializing critical care drug products, announced today that the company will deliver a presentation at the MoneyShow Las Vegas Virtual Expo that is being held August 18 – 20, 2020. Event: MoneyShow Las Vegas Virtual Expo Presentation Date: Wednesday, August 19, 2020 Presentation Time: 4:50 PM ET Mr. Leonard Mazur, Chairman of Citius, will provide an overview of the Company, including the recent closing of a $9.6 million public offering of common stock, and the recent submission of a briefing package to the FDA Division of Anti-Infective Products regarding Mino-Wrap, a novel approach to reducing post-operative infections associated with surgical implants. To listen to the live webcast, investors will need to register for the MoneyShow Las Vegas Virtual Expo first at the following link: Once registered, investors can then access the MoneyShow Las Vegas Virtual Expo platform beginning the morning of August 18, 2020 at: https://online.moneyshow.com/2020/august/moneyshow-las-vegas-virtual-expo/platform/login About Citius Pharmaceuticals, Inc.
Citius is a late-stage specialty pharmaceutical company dedicated to the development and commercialization of critical care products, with a focus on anti-infectives and cancer care. For more information, please visit www.citiuspharma.com.
Contact: Andrew Scott
SOURCE Citius Pharmaceuticals, Inc. | ||
Company Codes: NASDAQ-SMALL:CTXR |
View original content:
